Trading members of the Exchange are hereby informed that the under mentioned new securities of Jubilant Life Sciences Limited (Scrip Code: 530019) are listed and permitted for trading on the Exchange with effect from Wednesday, January 27, 2021.
|
Security Details
|
6,29,43,636 Equity Shares of Re. 1/- each issued pursuant to Composite Scheme of Arrangement between HSB Corporate Consultants Private Limited, Jubilant Stock Holding Private Limited, SSB Consultants & Management Services Private Limited, JCPL Life Science Ventures and Holdings Private Limited, JSPL Life Science Services and Holdings Private Limited and Jubilant Life Sciences Limited
These shares are ranking pari-passu with the existing equity shares of the company.
|
|
ISIN
|
INE700A01033
|
|
Dist. Nos.
|
222256776 to 285200411
|
|
Date of Allotment
|
18/01/2021 - 6,29,43,636 Shares
|
Please note that pre-scheme 6,29,43,636 equity shares held by HSB Corporate Consultants Private Limited (Transferor Company 1), Jubilant Stock Holding Private Limited (Transferor Company 2) and SSB Consultants & Management Services Private Limited (Transferor Company 3) in Jubilant Life Sciences Limited shall be cancelled on account of cross-holding and further 6,29,43,636 equity shares bearing distinctive nos. 159313140 to 222256775 allotted on 08/01/2021 to the shareholders [i..e. JCPL Life Science Ventures and Holdings Private Limited (Transferor Company 4) and JSPL Life Science Services and Holdings Private Limited (Transferor Company 5)] of HSB Corporate Consultants Private Limited (Transferor Company 1), Jubilant Stock Holding Private Limited (Transferor Company 2) and SSB Consultants & Management Services Private Limited (Transferor Company 3) in Step 1 of Composite Scheme of Arrangement pursuant to the amalgamation of HSB Corporate Consultants Private Limited (Transferor Company 1), Jubilant Stock Holding Private Limited (Transferor Company 2) and SSB Consultants & Management Services Private Limited (Transferor Company 3) with Jubilant Life Sciences Limited, will be cancelled immediately at the time of allotment of aforesaid 6,29,43,636 equity shares bearing distinctive nos. 222256776 to 285200411 allotted on 18/01/2021 to shareholders of JCPL Life Science Ventures and Holdings Private Limited (Transferor Company 4) and JSPL Life Science Services and Holdings Private Limited (Transferor Company 5) in Step 2 of the Composite Scheme of Arrangement pursuant to the amalgamation of JCPL Life Science Ventures and Holdings Private Limited (Transferor Company 4) and JSPL Life Science Services and Holdings Private Limited (Transferor Company 5) with Jubilant Life Sciences Limited.
Nitinkumar Pujari
Senior Manager |